GMAB Genmab A/S
Healthcare$26.87-0.67%ClosedMarket Cap: $16.50B
As of 2026-05-25
Institutional Ownership Summary
Investors Holding
294
13F Shares
73,220,359
Ownership %
11.9%
New Positions
74
Increased Positions
200
Closed Positions
37
Reduced Positions
52
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| Loncar Cancer Immunotherapy ETF | 35,793 | 3.42% | |
| Tema Oncology ETF | 182,924 | 2.95% | |
| AdvisorShares Dorsey Wright | 30,853 | 1.85% | |
| iShares Biotechnology ETF | 3,555,098 | 1.18% | |
| 28,651 | 0.17% | ||
| Avantis International Equity ETF | 463,846 | 0.09% | |
| Fidelity Enhanced International ETF | 155,891 | 0.05% | |
| Avantis International Large Cap Value ETF | 17,483 | 0.04% | |
| Fidelity Nasdaq Composite Index ETF | 25,559 | 0.01% | |
| Dimensional - International Core Equity Market ETF | 22,620 | 0.00% | |
| First Trust NYSE Arca Biotechnology Index Fund | 2,385,267 | 0.00% | |
| First Trust Nasdaq BuyWrite Income ETF | 70,256 | 0.00% |